Mary Scoviak

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, discusses what to expect from Maui Derm NP+PA Summer 2022 Conference.

Infusion centers are very much affected by legislative action on drugs. An expert offers insights into how best to navigate the situation.

Darrell S. Rigel, MD, MS, FAAD, answers the question of what is up coming in the world of dermatology in the way of precision medicine.

Darrell S. Rigel, MD, MS, delves into the power and potential of precision medicine in diagnosis, prognosis and therapy selection.

The AAD recently added topical tirbanibulin (Klisyri: Almirall) to its list of recommended therapies for treating AK.

Matthew Zirwas, MD, shares his step-by-step pearls for quelling this pruritic skin condition.

A poster presented at the 2022 American College of Mohs Surgery Annual Meeting not only suggested a link between multiple myeloma and a heightened rate of melanoma, but also demonstrated potential for higher overall mortality rates.

Dermatology has enjoyed one of the lowest litigation rates among medical specialties, but recent findings presented at the 2022 American College of Mohs Surgery Annual Meeting caution that mounting risks relating to procedural dermatology and cutaneous oncology could change that.

Is rosacea being confused with acne? Are physicians treating the their patients with the patient’s expectations in mind? Questions like these are more are answered by Adebola Dele-Michael, MD.

Matthew J. Zirwas, MD, detailed best-practice tactics for addressing this category of itch in a presentation at New Wave Dermatology Conference.

In a presentation at New Wave Dermatology Conference, Matthew Zirwas, MD, delved into why atopic dermatitis (AD) should be the first condition that comes to mind when an adult patient presents with dermatitis, why presentation is different in pediatric and adult patients, and why treating AD is abou…

A clinician updates the conventional wisdom on acne’s variations in patients of color, offering pearls from her practice and practical takeaways from recent research.

Two experts offer a step-by-step guide to creating an effective multidisciplinary treatment team.

Susan Kendig, WHNP, JD, detailed how nurse practitioners working in telehealth can limit their liability and protect their practices in her session on legal issues.

At the Society of Dermatology Nurse Practitioners Annual Symposium, Susan Kendig, WHNP, JD, shared insights to lead to better outcomes and decreased liability throughout the patient journey, from diagnosis and follow-up to EMRs.

At the opening session of the Society of Dermatology Nurse Practitioners Annual Symposium, Kathleen Haycraft, DNP, FNP-BC, DCNP, FAANP, delved into the revolutionary and evolutionary advances shaping dermatology in 2022.

In a health care industry where 75% of today’s professionals may no longer still be working in the sector by 2025, the number of nurse practitioners (NPs) is growing.1There are approximately 355,000 NPs in the United States and all are pivotal in patient care. This number is a 9% increase from 2021 and of that number, more than 5,000 are dermatology NPs.2 As Kathleen Haycraft, DNP, FNP-BC, DCNP, FAANP, a member of the board of directors, American Association of Nurse Practitioners, in Austin, Te…

Experts take a closer look at when to watch, and what to watch for in patients on JAK inhibitors.

Now, with an increasing emphasis on multidisciplinary tumor review boards and heightened expectations for pipeline drugs, physicians have new tools for building treatment plans that may push response rates beyond the 30% range.

The Science Behind Using Circulating Tumor DNA for MCC